These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27110643)

  • 1. Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance.
    Thomas K; Canedo J; Perry PJ; Doroudgar S; Lopes I; Chuang HM; Bohnert K
    Accid Anal Prev; 2016 Jul; 92():240-4. PubMed ID: 27110643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic marijuana use on driving performance.
    Doroudgar S; Mae Chuang H; Bohnert K; Canedo J; Burrowes S; Perry PJ
    Traffic Inj Prev; 2018; 19(7):680-686. PubMed ID: 30411981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
    Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
    Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Dextromethorphan on Driving Performance and the Standardized Field Sobriety Test.
    Perry PJ; Fredriksen K; Chew S; Ip EJ; Lopes I; Doroudgar S; Thomas K
    J Forensic Sci; 2015 Sep; 60(5):1258-62. PubMed ID: 26294136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults.
    Diaper A; Hindmarch I
    Phytother Res; 2004 Oct; 18(10):831-6. PubMed ID: 15551388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
    Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
    Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects.
    Glass JR; Sproule BA; Herrmann N; Streiner D; Busto UE
    J Clin Psychopharmacol; 2003 Jun; 23(3):260-8. PubMed ID: 12826988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose mirtazapine on driving performance in healthy volunteers.
    Iwamoto K; Kawano N; Sasada K; Kohmura K; Yamamoto M; Ebe K; Noda Y; Ozaki N
    Hum Psychopharmacol; 2013 Sep; 28(5):523-8. PubMed ID: 23813948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects.
    Anderson GD; Elmer GW; Kantor ED; Templeton IE; Vitiello MV
    Phytother Res; 2005 Sep; 19(9):801-3. PubMed ID: 16220575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers.
    Iudice A; Bonanni E; Maestri M; Nucciarone B; Brotini S; Manca L; Iudice G; Murri L
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):304-9. PubMed ID: 12139207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Standardized Field Sobriety Tests (SFST) and measures of cognitive functioning.
    Downey LA; Hayley AC; Porath-Waller AJ; Boorman M; Stough C
    Accid Anal Prev; 2016 Jan; 86():90-8. PubMed ID: 26528800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
    Cuellar NG; Ratcliffe SJ
    Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.
    Anderson GD; Elmer GW; Taibi DM; Vitiello MV; Kantor E; Kalhorn TF; Howald WN; Barsness S; Landis CA
    Phytother Res; 2010 Oct; 24(10):1442-6. PubMed ID: 20878691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control: Study Protocol Clinical Trial (SPIRIT Compliant).
    Iwata M; Iwamoto K; Kambe D; Tachibana N; Ando M; Ozaki N
    Medicine (Baltimore); 2020 Mar; 99(12):e19395. PubMed ID: 32195934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
    Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
    Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
    Dietz BM; Mahady GB; Pauli GF; Farnsworth NR
    Brain Res Mol Brain Res; 2005 Aug; 138(2):191-7. PubMed ID: 15921820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.